Fidelis Insurance Holdings Ltd. FIHL 深 沪
已收盘 08-15 16:00:00 美东时间
16.28
-0.830
-4.85%
华盛通- 最 高17.13
- 今 开17.05
- 成交量 115.22万股
- 最 低 15.935
- 昨 收 17.11
- 总市值 17.91亿
- 52周最高 21.02
- 市盈率 静 16.61
- 换手率 0.00%
- 52周最低 13.97
- 委 比 -95.12%
- 总股本 1.10亿
- 历史最高 21.02
- 量 比 1.67
- 振 幅 6.98%
- 历史最低 10.95
- 每 手 1
- 风险率 2.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fidelis targets 6–10% full-year underwriting growth following completion of Russia-Ukraine exposure resolution
Earnings Call Insights: Fidelis Insurance Holdings Limited (FIHL) Q2 2025 Management View CEO Daniel Burrows opened by highlighting Fidelis’ transformation into a market leader with a “high-quality sc...
08-15 01:47
Fidelis Insurance Hldgs Q2 Adj. EPS $0.12 Beats $(0.36) Estimate, Sales $589.300M Miss $681.957M Estimate
Fidelis Insurance Hldgs (NYSE:FIHL) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $(0.36) by 133.06 percent. This is a 77.78 percent decrease over earnings of $0.54 per share
08-14 04:18
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
A Look Ahead: Fidelis Insurance Hldgs's Earnings Forecast
Fidelis Insurance Hldgs (NYSE:FIHL) is set to give its latest quarterly earning...
08-13 00:02
Fidelis Insurance Group Expands Capital Management Initiatives With $200M Share Repurchase Renewal, Boosts Quarterly Dividend To $0.15/Shr
Renews common share repurchase authorization, bringing the total current authorization to $200 millionIncreases common share quarterly dividend to $0.15 per shareFidelis Insurance Holdings Limited (NYSE:FIHL) ("Fidelis
08-06 22:02
美股大行评级 | 潜在涨幅336.36%！Canaccord Genuity上调ATAI Life Sciences目标价至12美元，维持"买入"评级
Redburn Atlantic：下调Adobe(ADBE)评级至"卖出"，目标价从420美元降至280美元
07-03 11:01
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Keefe, Bruyette & Woods Maintains Outperform on Fidelis Insurance Hldgs, Raises Price Target to $21
Keefe, Bruyette & Woods analyst Meyer Shields maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a Outperform and raises the price target from $20 to $21.
07-02 01:43
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
JMP Securities Maintains Market Outperform on Fidelis Insurance Hldgs, Raises Price Target to $27
JMP Securities analyst Matthew Carletti maintains Fidelis Insurance Hldgs (NYSE:FIHL) with a Market Outperform and raises the price target from $24 to $27.
05-16 23:58
